Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
20.0%
% of SBIO's 90 holdings also in BBP
27.9%
% of BBP's 65 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.9% | 2.2% | 2.2% |
 |
AXSOME THERAPEUTICS, INC. | 4.4% | 2.1% | 2.1% |
|
PTC THERAPEUTICS INC | 3.6% | 1.8% | 1.8% |
|
MIRUM PHARMACEUTICALS, INC. | 1.8% | 1.7% | 1.7% |
|
ACADIA PHARMACEUTICALS INC | 2.3% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to BBP
 |
ALKERMES PLC | 4.1% |
|
AVIDITY BIOSCIENCES INC | 3.1% |
 |
MERUS N.V. | 2.9% |
|
AKERO THERAPEUTICS, INC. | 2.9% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.8% |
|
CRINETICS PHARMACEUTICALS INC | 2.7% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 2.4% |
|
AXSOME THERAPEUTICS, INC. | 2.3% |
|
RHYTHM PHARMACEUTICALS, INC. | 2.3% |
|
VERICEL CORPORATION | 2.0% |
SBIO Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
BEIGENE LTD. SPONSORED ADR | -2.3% |
|
SAGE THERAPEUTICS INC | -2.2% |
|
GILEAD SCIENCES INC | -2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.1% |
|
HALOZYME THERAPEUTICS INC | -2.1% |
|
TG THERAPEUTICS INC | -2.1% |
|
AMGEN INC | -2.0% |
|
BRIDGEBIO PHARMA, INC. | -1.9% |
|
ASCENDIS PHARMA A/S | -1.8% |